Medication info
Rozaalpos 5/50 mg (Amlodipine, Losartan Potassium)

Rozaalpos 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201603728 · Approved 2016.06.22

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be made taking into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in patients with reduced effective intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with amlodipine or losartan alone. Additionally, it assists in managing blood pressure effectively when used as an initial treatment in stage 2 hypertension patients who require combination therapy to reach their target blood pressure. Therefore, this drug plays a significant role in the treatment of hypertension and improves blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be made taking into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in patients with reduced effective intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial losartan dose of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters. If pregnancy is confirmed, discontinue use immediately. When this medication is administered for the first time to patients with low intravascular blood volume, hypotension may occur, so these patients should stabilize their condition before administration. Patients with allergies to any of the components in this medication, pregnant or breastfeeding women, those with severe liver disease, severe aortic stenosis patients, or those in a state of shock should not take this medication. Patients with reduced intravascular blood volume, those requiring strict sodium restriction, patients with moderate to severe renal impairment, and those with hyperkalemia should use this medication with caution. While taking this medication, symptoms such as dizziness, headache, or drowsiness may occur, so care is needed when engaging in dangerous tasks such as working at heights or driving. If taken in combination with other antihypertensive agents, the blood pressure-lowering effect may be enhanced, so it is essential to follow the physician’s instructions. Taking this medication with grapefruit juice may increase its blood concentration and elevate the risk of side effects, so it is advisable to avoid it. It is safer for pregnant or breastfeeding women not to take this medication, especially during pregnancy when it poses a risk to the fetus; discontinuation is necessary. The safety and efficacy of this medication for children have not been established, so it is recommended that children under the age of 18 do not take it. In cases of overdose, severe hypotension or arrhythmias may occur, so the dosage must be strictly adhered to, and in the case of an overdose, immediate medical attention is required. This medication should be stored out of the reach of children, and it is important not to transfer it to another container to maintain its quality.

Side effects

Dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, depression, abdominal discomfort, indigestion, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, ocular congestion, frequent urination, fatigue, edema, vasculitis, tension headache, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, lumbago, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, rhinitis, alopecia, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary dysfunction, nocturia, hepatitis, jaundice, elevated liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, skin erythema, papular rash, heaviness, warmth sensation, impaired glucose tolerance, weakness, muscle spasms, lumbago, leg pain, congestion, upper respiratory infection, sinusitis, sinus disorder, pharyngitis, myalgia, swelling, loss of appetite, toothache, flatulence, gastritis, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle stiffness, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory decrease, decreased libido, cognitive dysfunction, migraine, neuralgia, panic disorder, sleep disorder, bronchitis, pharyngeal discomfort, epistaxis, respiratory congestion, dermatitis, skin dryness, petechiae, erythema, photosensitivity, sweating, blurred vision, burning sensation and pain in the eyes, conjunctivitis, dysgeusia, tinnitus, vision impairment, urethral infection, angioedema, vasculitis, anaphylactic reaction, liver dysfunction, intestinal vasculitis, lethargy, rhabdomyolysis, dysgeusia, dry cough, erythema, hyperkalemia, hyponatremia, elevated ALT, increased serum creatinine, elevated liver enzymes or serum bilirubin, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.